Oxford, United Kingdom
ONI, founded in 2016, is a pioneering company headquartered in the United Kingdom, operating at the intersection of Biotechnology and Life Sciences. Their core innovation is The Nanoimager, the world's first desktop compatible compact super-resolution microscope, designed to provide unprecedented visibility into proteins, DNA, and RNA within nanoparticles, viruses, bacteria, cells, and tissue.
ONI's mission is to democratize access to advanced scientific tools, fueled by a drive to push the boundaries of scientific discovery through affordability and accessibility. The company's commitment manifests in their continuous effort to lower barriers for researchers seeking to ask and answer previously unapproachable questions.
In its latest financial milestone, ONI secured a $75.00M Series B investment on 24 December 2021, led by prominent investors such as Arch Venture Partners, Casdin Capital, Axon Ventures, Oxford Science Enterprises, Section 32, Vertical Venture Partners, and Artis Ventures (AV). This substantial backing underscores the market confidence in ONI's potential to transform molecular research landscapes.
